In the pharmaceutical sector, Turkey has an important place both in terms of sales volume, investments made in Turkey through indigenization and export opportunities to potential growth markets due to its geopolitical location. As Haver Farma İlaç, we aim to continuously improve our product portfolio by closely following the developments in the health sector, and to become a preferred company in national and international markets by realising dynamic and pioneering structuring in the areas we serve. With this vision, we have prioritised our R&D investments and focused on high value-added products and exportable products. Our organisation progresses step by step towards its goals with the values agreed upon with its employees. Sensitive to the environment and aiming at continuous development with innovative technologies and approaches, does not give up the search for better and realises all these with the effort to provide services based on holistic quality understanding, without leaving the understanding of honesty and honesty, carrying the high level of responsibility that we produce benefits for health, Haver Farma İlaç has accelerated its efforts to become a leading player not only in our country but also in international markets.
